Opus Genetics Files 8-K
Ticker: IRD · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1228627
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Opus Genetics filed a routine 8-K on 6/26/25. No major news.
AI Summary
Opus Genetics, Inc. filed an 8-K on June 26, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events or financial figures within the provided text, but it confirms the company's reporting status.
Why It Matters
This filing indicates Opus Genetics is meeting its regulatory reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine SEC filing with no new material information disclosed.
Key Players & Entities
- Opus Genetics, Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-34079 (identifier) — Commission File Number
- 11-3516358 (identifier) — IRS Employer Identification No.
- 8 Davis Drive Durham , NC 27713 (address) — Address of principal executive offices
- 248-957-9024 (phone_number) — Registrant's telephone number
FAQ
What specific event triggered this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as items, but the provided text does not detail the specific event.
When was the earliest event reported in this filing?
The earliest event reported was on June 26, 2025.
What is Opus Genetics, Inc.'s state of incorporation?
Opus Genetics, Inc. is incorporated in Delaware.
What is the company's principal executive office address?
The principal executive offices are located at 8 Davis Drive, Durham, NC 27713.
Does this filing contain any new financial results?
The filing lists 'Financial Statements and Exhibits' but the provided text does not include specific financial results.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Opus Genetics, Inc. (IRD).